0001209191-22-034175.txt : 20220603
0001209191-22-034175.hdr.sgml : 20220603
20220603170036
ACCESSION NUMBER: 0001209191-22-034175
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220601
FILED AS OF DATE: 20220603
DATE AS OF CHANGE: 20220603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Donnell Niall
CENTRAL INDEX KEY: 0001780235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40315
FILM NUMBER: 22995534
MAIL ADDRESS:
STREET 1: C/O RIVERVEST VENTURE PARTNERS
STREET 2: 101 SOUTH HANLEY RD., STE 1850
CITY: ST. LOUIS
STATE: MO
ZIP: 63105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001637715
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472309515
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18575 JAMBOREE ROAD
STREET 2: SUITE 275-S
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: (858) 283-0280
MAIL ADDRESS:
STREET 1: 18575 JAMBOREE ROAD
STREET 2: SUITE 275-S
CITY: IRVINE
STATE: CA
ZIP: 92612
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-01
0
0001637715
Reneo Pharmaceuticals, Inc.
RPHM
0001780235
O'Donnell Niall
C/O RENEO PHARMACEUTICALS, INC.
18575 JAMBOREE ROAD, SUITE 275-S
IRVINE
CA
92612
1
0
0
0
Stock Option (right to buy)
2.09
2022-06-01
4
A
0
17500
0.00
A
2032-05-31
Common Stock
17500
17500
D
The shares subject to the option vest on the earlier of June 1, 2023 or the day prior to the date of the Issuer's 2023 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.
/s/ Gregory J. Flesher, Attorney-in-Fact
2022-06-03